Bridgefront Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bridgefront Capital’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell
2025 Q2	$370K	Buy
2024 Q4	–	Sell
2024 Q3	$579K	Buy
2022 Q2	–	Sell
2022 Q1	$340K	Buy
2021 Q4	–	Sell
2021 Q3	$435K	Buy
2021 Q2	$216K	Buy